Enanta Pharmaceuticals | 자산





자산 변화 날짜
AbbVie USD 133.9B 3.28B 2025-09
Amgen USD 90.59B 445M 2025-12
Anika Therapeutics USD 189.44M 1.76M 2025-09
Arrowhead Research USD 1.6B 218.89M 2025-12
AstraZeneca USD 114.46B 2.03B 2025-09
BioCryst Pharmaceuticals USD 446.42M 10.76M 2025-09
Biogen USD 29.44B 232M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Enanta Pharmaceuticals USD 280.73M 20.3M 2025-09
Gilead Sciences USD 58.53B 2.81B 2025-09
GlaxoSmithKline GBP 61.12B 221M 2025-12
Halozyme Therapeutics USD 2.22B 167.33M 2025-09
Heron Therapeutics USD 248.95M 16.86M 2025-09
Immunic USD 40.7M 20.72M 2025-09
Incyte USD 6.96B 627.62M 2025-12
Insmed USD 2.36B 119.12M 2025-09
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
J&J USD 192.82B 573M 2025-09
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Ligand Pharmaceuticals USD 1.48B 528.17M 2025-09
Merck USD 129.55B 12.02B 2025-09
Neurocrine Biosciences USD 4.27B 375.9M 2025-09
Novartis USD 107.29B 2.89B 2025-09
Novavax USD 1.18B 156.66M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.64B 9.54M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Vertex Pharmaceuticals USD 24.86B 825.6M 2025-09


Enanta Pharmaceuticals 자산 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.